PIPR Q3 2025 Deep Dive: Sector Diversification and Advisory Growth Amid Market Volatility

Investment banking firm Piper Sandler (NYSE:PIPR) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 33.3% year on year to $479.3 million.

Is now the time to buy PIPR? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Despite exceeding Wall Street’s revenue and non-GAAP profit expectations in Q3, Piper Sandler’s results were met with a negative market reaction. Management attributed the quarter’s strong financial performance to increased activity in equity capital markets, especially within health care and financial services. CEO Chad Abraham emphasized, “We have now achieved 8 consecutive quarters of year-over-year growth, underscoring our consistent execution and sustained momentum.” However, leadership acknowledged that the outperformance was partly due to unusually high activity levels in corporate financing, cautioning that some of this momentum might not persist into the next quarter.

Looking forward, Piper Sandler’s outlook is shaped by anticipated continued strength in M&A advisory and a robust pipeline across its sector franchises. Management is optimistic about further gains in non-M&A advisory, debt capital markets, and the technology sector following recent hires and acquisitions. CFO Kate Clune noted that while operating margins have improved, the company remains focused on “opportunities for discipline and leverage as the top line continues to improve.” Leadership also flagged potential headwinds, including market valuations and external disruptions such as government shutdowns, which could impact deal activity and financing.

Key Insights from Management’s Remarks

Management pointed to diversified sector performance, a surge in bank M&A activity, and investments in advisory capabilities as key drivers behind Q3’s results and future opportunities.

• Bank M&A resurgence: Piper Sandler’s Financial Services group benefited from a notable increase in U.S. bank mergers, advising on 6 of the 10 largest deals closed during the quarter. This resurgence supported both M&A advisory and related balance sheet restructuring activity, broadening revenue streams.
• Health care and biotech momentum: The health care franchise delivered strong results, with the firm serving as book runner on all 13 equity deals for health care companies in Q3. Management highlighted an improved capital raising environment for biotech, fueled by M&A activity and lower interest rates.
• Non-M&A advisory expansion: The company’s investments in debt capital markets advisory, restructuring, and private capital advisory have resulted in faster growth rates compared to traditional M&A. Larger agented debt deals, some exceeding $400 million, are becoming more common, and the recently acquired Aviditi team has contributed to notable secondary transactions.
• Technology group build-out: With the recent acquisition of G Squared and the hiring of managing directors focused on government services and artificial intelligence, Piper Sandler is expanding its technology investment banking capabilities. Management views this sector as a top priority for growth over the next several years.
• Public finance and fixed income resilience: The public finance business outpaced overall market growth in municipal issuance, while the fixed income division benefited from increased activity due to anticipation of further rate cuts. These segments provided diversification and helped offset volatility in other areas.

Drivers of Future Performance

Piper Sandler’s guidance is driven by a strong advisory pipeline, continued sector diversification, and a focus on leveraging operational scale, though management remains cautious about external risks.

• Advisory pipeline robustness: Management expects continued momentum in M&A and non-M&A advisory, particularly in financial services, health care, and technology. The pipeline is described as “robust and building,” with Q4 advisory revenues anticipated to be similar to last year’s strong finish, barring unforeseen market disruptions.
• Operational leverage focus: CFO Kate Clune highlighted that margin improvement is not capped at current levels, with further operating discipline and scale expected to drive profitability as revenues grow. Management is targeting ongoing efficiency even as it invests in strategic hires and platform expansion.
• External headwinds and uncertainties: Leadership identified risks such as stagnant depository stock valuations and potential government shutdowns, which could disrupt deal flow and financing activity. The timing of interest rate cuts and the normalization of the yield curve are also expected to influence client engagement, particularly in fixed income and municipal finance.

Catalysts in Upcoming Quarters

Looking ahead, our analysts will be tracking (1) the pace of bank M&A activity and the ability to capitalize on balance sheet restructurings, (2) further expansion and revenue contribution from the technology investment banking group, and (3) normalization trends in fixed income and municipal finance as interest rates evolve. Continued growth in non-M&A advisory and resilience across diversified sectors will also be important indicators of Piper Sandler’s execution.

Piper Sandler currently trades at $319.26, down from $326.70 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free for active Edge members).

Our Favorite Stocks Right Now

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.